The CBFβ subunit is essential for CBFα2 (AML1) function in vivo

Cell

Volumn 87, Issue 4, 1996, Pages 697-708

  Wang, Qing ^a   Stacy, Terryl ^a   Miller, Janelle D ^a   Lewis, Amy F ^a   Gu, Ting Lei ^a   Huang, Xuemei ^b   Bushweller, John H ^b   Bories, Jean Christophe ^c,f   Alt, Frederick W ^c   Ryan, Gabriella ^d   Liu, Pu Paul ^d   Wynshaw Boris, Anthony ^d   Binder, Michael ^a   Marín Padilla, Miguel ^a   Sharpe, Arlene H ^e   Speck, Nancy A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Dartmouth College ^*  (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; CBFB PROTEIN, MOUSE; CORE BINDING FACTOR BETA; DNA BINDING PROTEIN; MESSENGER RNA; ONCOPROTEIN; RUNX1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR RUNX1;

ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; DNA BINDING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LETHAL GENE; PRIORITY JOURNAL; ALLELE; ANIMAL; BAGG ALBINO MOUSE; BLEEDING; BLOOD CELL; C57BL MOUSE; CENTRAL NERVOUS SYSTEM; CROSS BREEDING; EMBRYO; GENE DOSAGE; GENETICS; GENOTYPE; HEMATOPOIESIS; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; LIVER; METABOLISM; MOUSE; MOUSE MUTANT; MUTAGENESIS; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRENATAL DEVELOPMENT; PROTEIN BINDING; STEM CELL;

ALLELES; ANIMALS; BLOOD CELLS; CENTRAL NERVOUS SYSTEM; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; CROSSES, GENETIC; DNA-BINDING PROTEINS; EMBRYO; GENE DOSAGE; GENES, LETHAL; GENOTYPE; HEMATOPOIESIS; HEMORRHAGE; IN SITU HYBRIDIZATION; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTAGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; STEM CELLS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

EID: 0030588487     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81389-6     Document Type: Article

References (46)

1. Andres, K.H. (1967). Über die Feinstruktur der arachnoidea und dura mater von mammalia. Z. Zellforsch. Mikrosk. Anat. 82, 272-295.
2. Bae, S.C., Yamaguchi-Iwai, Y., Ogawa, E., Maruyama, M., Inuzuka, M., Kagoshima, H., Shigesada, K., Satake, M., and Ito, Y. (1993). Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8, 809-814.
3. Bae, S.-C., Takahashi, E., Zhang, Y. W., Ogawa, E., Shigesada, K., Namba, Y., Satake, M., and Ito, Y. (1995). Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain. Gene 159, 245-248.
4. Bitter, M.A., LeBeau, M.M., Rowley, J.D., Larson, R.A., Golomb, H.M., and Vardiman, J.W. (1987). Association between morphology, karyotype, and clinical features in myeloid leukemias. Hum. Pathol. 18, 211.
5. Bowie, J.U., and Sauer, R.T. (1989). Identification of C-terminal extensions that protect proteins from intracellular proteolysis. J. Biol. Chem. 264, 7596-7602.
6. Castilla, L.H., Wijmenga, C., Wang, Q., Stacy, T., Speck, N.A., Eckhaus, M., Marín-Padilla, M., Collins, F.S., Wynshaw-Boris, A., and Liu, P.P. (1996). Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell, this issue.
7. Golling, G., Li, L.-H., Pepling, M., Stebbins, M., and Gergen, J.P. (1996). Drosophila homologues of proto-oncogene product PEBP2/ CBFβ regulate the DNA-binding properties of Runt. Mol. Cell. Biol. 16, 932-942.
8. Golub, T.R., Barker, G.F., Bohlander, S.K., Hiebert, S., Ward, D.C., Bray-Ward, P., Morgan, E., Raimondi, S.C., Rowley, J.D., and Gilliland, D.G. (1995). Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 92, 4917-4921.
9. Harlow, E., and Lane, D. (1988). Antibodies: A Laboratory Manual (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory).
10. Jonsen, M.D., Petersen, J.M., Xu, Q.-P., and Graves, B.J. (1996). Characterization of cooperative function of inhibitory sequences in Ets-1. Mol. Cell. Biol. 16, 2065-2073.
11. Kamachi, Y., Ogawa, E., Asano, M., Ishida, S., Murakami, Y., Satake, M., Ito, Y., and Shigesada, K. (1990). Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J. Virol. 64, 4808-4819.
12. Krisch, B., Leonhardt, H., and Oksche, A. (1984). Compartment and perivascular arrangement of the meninges covering the cerebral cortex of the rat. Cell Tiss. Res. 238, 459-474.
13. Levanon, D., Negreanu, V., Bernstein, Y., Bar-Am, I., Avivi, L., and Groner, Y. (1994). AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23, 425-432.
14. Li, E., Bestor, T.H., and Jaenisch, R. (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926.
15. Liu, P., Tarle, S.A., Hajra, A., Claxton, D.F., Marlton, P., Freedman, M., Siciliano, M.J., and Collins, F.S. (1993). Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 261, 1041-1044.
16. Marín-Padilla, M. (1985). Early vascularization of the embryonic cerebral cortex: golgi and electron microscopic studies. J. Comp. Neurol. 241, 237-249.
17. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., and Ohki, M. (1991). t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88, 10431-10434.
18. Moore, M.A.S., and Metcalf, D. (1970). Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br. J. Haematol. 18, 279-296.
19. Mortensen, R.M., Conner, D.A., Chao, S., Geisterfer-Lowrance, A.A.T., and Seidman, J.G. (1992). Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell Biol. 12, 2391-2395.
20. Mucenski, M.L., McLain, K., Kier, A.B., Swerdlow, S.H., Schreiner, C.M., Miller, T.A., Pietryga, D.W., Scott, Jr., W.J., and Potter, S.S. (1991). A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65, 677-689.
21. Nucifora, G., Begy, C.R., Erickson, P., Drabkin, H.A., and Rowley, J.D. (1993). The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc. Natl. Acad. Sci. USA 90, 7784-7788.
22. Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y., and Shigesada, K. (1993a). Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 194, 314-331.
23. Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., and Ito, Y. (1993b). PEBP2/PEA2 represents a new family of transcription factor homologous to the products of the Drosophila runt and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90, 6859-6863.
24. Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G., and Downing, J.R. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330.
25. Orkin, S.H. (1995). Transcription factors and hematopoietic development. J. Biol. Chem. 270, 4955-4958.
26. Pandolfi, P.P., Roth, M.E., Karis, A., Leonard, M.W., Dzierzak, E., Grosveld, F.G., Douglas, E., and Lindenbaum, M.H. (1995). Targeted disruption of the GATA-3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nature Genet. 11, 40-44.
27. Pevny, L., Simon, M.C., Robertson, E., Klein, W.H., Tsai, S.-F., D'Agati, V., Orkin, S.H., and Constantini, F. (1991). Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349, 257-260.
28. Romana, S.P., Mauchauffe, M., Le Coniat, M., Chumakow, I., Le Paslier, D., Berger, R., and Bernard, O.A. (1995). The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85, 3662-3670.
29. Rosen, B., and Beddington, R.S. (1993). Whole-mount in situ hybridization in the mouse embryo: gene expression in three dimensions. Trends Genet. 9, 162-167.
30. Satake, M., Nomura, S., Yamaguchi-Iwai, Y., Takahama, Y., Hashimoto, Y., Niki, M., Yukihiko, K., and Ito, Y. (1995). Expression of the Runt domain encoding PEBP2α genes in T cells during thymic development. Mol. Cell. Biol. 15, 1662-1670.
31. Scott, E.W., Simon, M.C., Anastasi, J., and Singh, H. (1994). Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573-1577.
32. Shivdasani, R.A., Mayer, E.L., and Orkin, S.H. (1995). Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373, 432-434.
33. Shurtleff, S.A., Meyers, S., Hiebert, S.W., Raimondi, S.C., Head, D.R., Willman, C.L., Wolman, S., Slovak, M.L., Carroll, A.J., Behm, F., et al. (1995). Heterogeneity in CBFB/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood 85, 3695-3703.
34. Simeone, A., Daga, A., and Calabi, F. (1995). Expression of runt in the mouse embryo. Dev. Dyn. 203, 61-70.
35. Soifer, S.J., Peters, K.G., O'Keefe, J., and Coughlin, S.R. (1994). Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Amer. J. Pathol. 144, 60-69.
36. Speck, N.A., and Stacy, T. (1995). A new transcription factor family associated with human leukemias. In Critical Reviews in Eukaryotic Gene Expression, G.S. Stein, J.L. Stein, and J.B. Lian, eds. (New York: Begell House, Inc.), pp. 337-364.
37. Thornell, A., Hallberg, B., and Grundstrom, T. (1991). Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences. J. Virol. 65, 42-50.
38. Tsai, J.-Y., Keller, T., Kuo, F.C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F.W., and Orkin, S.H. (1994). An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371, 221-226.
39. Valge-Archer, V.E., Osada, H., Warren, A.J., Forster, A., Li, J., Baer, R., and Rabbitts, T.H. (1994). The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc. Natl. Acad. Sci. USA 91, 8617-8621.
40. Wang, S., and Speck, N.A. (1992). Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol. Cell. Biol. 12, 89-102.
41. Wang, S., Wang, Q., Crute, B.E., Melnikova, I.N., Keller, S.R., and Speck, N.A. (1993). Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13, 3324-3339.
42. Wang, Q., Stacy, T., Binder, M., Marín-Padilla, M., Sharpe, A.H., and Speck, N.A. (1996). Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93, 3444-3449.
43. Warren, A.J., Colledge, W.H., Carlton, M.B.L., Evans, M.J., Smith, A.J.H., and Rabbitts, T.H. (1994). The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell 78, 45-57.
44. Wilkinson, D.G. (1992). In Situ Hybridization: A Practical Approach (Oxford: Oxford University Press).
45. Williams, B.O., Schmitt, E.M., Remington, L., Bronson, R.T., Albert, D.M., Weinberg, R.A., and Jacks, T. (1994). Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13, 4251-4259.
46. Wong, P.M.C., Chung, S.W., Chui, D.H.K., and Eaves, C.J. (1986). Properties of the earliest clonogenic hemapoietic precursors to appear in the developing murine yolk sac. Proc. Natl. Acad. Sci. USA 83, 3851-3854.